William Blair Issues Pessimistic Outlook for USPH Earnings

U.S. Physical Therapy, Inc. (NYSE:USPH) – Equities researchers at William Blair dropped their Q4 2025 earnings estimates for shares of U.S. Physical Therapy in a note issued to investors on Wednesday, November 12th. William Blair analyst J. Haase now anticipates that the company will post earnings of $0.68 per share for the quarter, down from their prior estimate of $0.72. The consensus estimate for U.S. Physical Therapy’s current full-year earnings is $2.67 per share. William Blair also issued estimates for U.S. Physical Therapy’s Q1 2026 earnings at $0.57 EPS, Q2 2026 earnings at $0.82 EPS, Q3 2026 earnings at $0.85 EPS and Q4 2026 earnings at $0.78 EPS.

USPH has been the topic of a number of other reports. Weiss Ratings reissued a “hold (c)” rating on shares of U.S. Physical Therapy in a research report on Wednesday, October 8th. Wall Street Zen lowered U.S. Physical Therapy from a “buy” rating to a “hold” rating in a report on Sunday, September 21st. Barrington Research restated an “outperform” rating and issued a $103.00 price target on shares of U.S. Physical Therapy in a research note on Friday, October 24th. JPMorgan Chase & Co. began coverage on U.S. Physical Therapy in a research note on Thursday, September 18th. They set an “overweight” rating and a $110.00 price target for the company. Finally, Zacks Research upgraded U.S. Physical Therapy to a “hold” rating in a research report on Friday, August 8th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $110.25.

U.S. Physical Therapy Trading Down 0.5%

USPH traded down $0.33 during trading on Friday, hitting $70.90. 19,730 shares of the stock traded hands, compared to its average volume of 145,985. The firm has a 50-day moving average of $84.53 and a 200 day moving average of $80.08. U.S. Physical Therapy has a 12-month low of $62.77 and a 12-month high of $101.19. The firm has a market capitalization of $1.08 billion, a P/E ratio of 30.96, a price-to-earnings-growth ratio of 4.41 and a beta of 1.47. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.18 and a quick ratio of 1.18.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Tuesday, August 22nd. The company reported $0.90 EPS for the quarter. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.78%. The company had revenue of $140.66 million for the quarter.

U.S. Physical Therapy Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 12th. Investors of record on Monday, November 17th will be paid a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend is Monday, November 17th. U.S. Physical Therapy’s dividend payout ratio is presently 75.63%.

Insider Activity

In other news, CFO Carey P. Hendrickson sold 698 shares of the company’s stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $86.11, for a total transaction of $60,104.78. Following the completion of the transaction, the chief financial officer directly owned 27,808 shares of the company’s stock, valued at approximately $2,394,546.88. This represents a 2.45% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Christopher J. Reading sold 2,000 shares of U.S. Physical Therapy stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $83.53, for a total value of $167,060.00. Following the transaction, the chief executive officer directly owned 114,088 shares in the company, valued at approximately $9,529,770.64. This trade represents a 1.72% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 5,061 shares of company stock valued at $426,273. 2.00% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On U.S. Physical Therapy

Institutional investors have recently added to or reduced their stakes in the business. Envestnet Asset Management Inc. raised its holdings in U.S. Physical Therapy by 9.4% in the second quarter. Envestnet Asset Management Inc. now owns 346,160 shares of the company’s stock valued at $27,070,000 after buying an additional 29,671 shares during the period. Park Avenue Securities LLC acquired a new position in U.S. Physical Therapy during the 2nd quarter valued at about $481,000. Index Fund Advisors Inc. acquired a new stake in shares of U.S. Physical Therapy during the second quarter worth $352,000. Wealth Enhancement Advisory Services LLC purchased a new stake in shares of U.S. Physical Therapy in the second quarter valued at $341,000. Finally, Sowell Financial Services LLC purchased a new position in U.S. Physical Therapy during the second quarter valued at approximately $204,000.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.